These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1908381)

  • 21. Catheter-associated urinary tract infections: impact of catheter materials on their management.
    Kumon H; Hashimoto H; Nishimura M; Monden K; Ono N
    Int J Antimicrob Agents; 2001 Apr; 17(4):311-6. PubMed ID: 11295414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some observations on the activity of three antiseptics used as bladder irrigants in the treatment of urinary tract infection in patients with indwelling catheters.
    Stickler DJ; Plant S; Bunni NH; Chawla JC
    Paraplegia; 1981; 19(6):325-33. PubMed ID: 6796928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters.
    Jones GL; Muller CT; O'Reilly M; Stickler DJ
    J Antimicrob Chemother; 2006 Feb; 57(2):266-72. PubMed ID: 16339844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple additives to increase the activity of chlorhexidine digluconate against urinary pathogens.
    Harper WE
    Paraplegia; 1983 Apr; 21(2):86-93. PubMed ID: 6408586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activity of weak organic acids against uropathogens.
    Burns J; McCoy CP; Irwin NJ
    J Hosp Infect; 2021 May; 111():78-88. PubMed ID: 33545217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters.
    Williams GJ; Stickler DJ
    J Med Microbiol; 2008 Sep; 57(Pt 9):1135-1140. PubMed ID: 18719184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Biofilm Effect of Octenidine and Polyhexanide on Uropathogenic Biofilm-Producing Bacteria.
    Loose M; Naber KG; Purcell L; Wirth MP; Wagenlehner FME
    Urol Int; 2021; 105(3-4):278-284. PubMed ID: 33401282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013.
    Hayajneh WA; Hajj A; Hulliel F; Sarkis DK; Irani-Hakimeh N; Kazan L; Badal RE
    Int J Infect Dis; 2015 Jun; 35():56-61. PubMed ID: 25917963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of antibacterial activity of oral antibacterial agents against recently isolated bacteria of E. coli, Klebsiella, Citrobacter and Proteus from clinical materials of urinary tract infection (author's transl)].
    Okamoto Y; Maehara K; Ueda Y; Nasu M; Kamiki T; Iri H; Nagai T; Kumamoto Y; Sakai S; Shigeta S; Kosaki N; Oguri T
    Jpn J Antibiot; 1981 Jun; 34(6):959-75. PubMed ID: 7026823
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antimicrobial activity of ceftolozane/tazobactam against Enterobacteriaceae and Pseudomonas aeruginosa in the Czech Republic in 2016].
    Žemličková H; Jakubů V; Fridrichová M
    Klin Mikrobiol Infekc Lek; 2017 Dec; 23(4):132-135. PubMed ID: 29378381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of nosocomial urinary tract infections caused by multiply resistant gram-negative bacilli: potential use of antimicrobials "resistant" by disc-diffusion testing for controlling epidemics.
    Stamm WE; Arbaczawski J; Mackel DC; Anderson RL
    Infect Control; 1980; 1(3):157-64. PubMed ID: 6778835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological studies on some bladder irrigation fluids.
    Williams RJ; Hamilton-Miller JM; Brumfitt W
    Infection; 1976; 4(2):31-4. PubMed ID: 824207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacteriological studies in outpatients with acute urinary tract infections with particular reference to the resistance spectrum (author's transl)].
    Knothe H; Sietzen W
    Infection; 1976; 4(2):11-15. PubMed ID: 789245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some observations on the diffusion of antimicrobial agents through the retention balloons of foley catheters.
    Williams GJ; Stickler DJ
    J Urol; 2007 Aug; 178(2):697-701. PubMed ID: 17574612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of a silicone urinary catheter impregnated with chlorhexidine and triclosan against colonization with Proteus mirabilis and other uropathogens.
    Gaonkar TA; Caraos L; Modak S
    Infect Control Hosp Epidemiol; 2007 May; 28(5):596-8. PubMed ID: 17464922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F; Tassi C; Stagni GR
    Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
    [No Abstract]   [Full Text] [Related]  

  • 40. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan.
    Jones GL; Russell AD; Caliskan Z; Stickler DJ
    Eur Urol; 2005 Nov; 48(5):838-45. PubMed ID: 16126323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.